LeMaitre Vascular (LMAT) stock price, revenue, and financials

LeMaitre Vascular market cap is $663.9 m, and annual revenue was $117.23 m in FY 2019

$663.9 M

LMAT Mkt cap, 23-Oct-2020

$24.9 M

LeMaitre Vascular Revenue Q2, 2020
LeMaitre Vascular Gross profit (Q2, 2020)17 M
LeMaitre Vascular Gross profit margin (Q2, 2020), %68.5%
LeMaitre Vascular Net income (Q2, 2020)3.5 M
LeMaitre Vascular EBIT (Q2, 2020)4.9 M
LeMaitre Vascular Cash, 30-Jun-202020 M
LeMaitre Vascular EV688.2 M

LeMaitre Vascular Revenue

LeMaitre Vascular revenue was $117.23 m in FY, 2019 which is a 11% year over year increase from the previous period.

Embed Graph

LeMaitre Vascular Revenue Breakdown

Embed Graph

LeMaitre Vascular revenue breakdown by business segment: 51.0% from Lower Extremities, 31.0% from Carotid Artery and 18.0% from Other Areas

LeMaitre Vascular revenue breakdown by geographic segment: 53.9% from United States, 10.6% from Germany and 35.6% from Other Countries

LeMaitre Vascular Income Statement

Annual

USDFY, 2017FY, 2018FY, 2019

Revenue

100.9m105.6m117.2m

Revenue growth, %

5%11%

Cost of goods sold

30.2m31.6m37.4m

Gross profit

70.7m73.9m79.9m

Gross profit Margin, %

70%70%68%

Sales and marketing expense

25.9m27.3m30.3m

R&D expense

6.6m8.2m9.3m

General and administrative expense

17.0m17.7m19.1m

Operating expense total

49.6m45.7m58.7m

EBIT

21.1m28.2m21.2m

EBIT margin, %

21%27%18%

Interest expense

21.0k2.0k

Interest income

179.0k631.0k698.0k

Pre tax profit

21.1m28.4m21.7m

Income tax expense

3.9m5.5m3.7m

Net Income

17.2m22.9m17.9m

EPS

0.91.10.9

LeMaitre Vascular Balance Sheet

Annual

USDFY, 2017FY, 2018FY, 2019

Cash

19.1m26.3m11.8m

Accounts Receivable

15.0m15.7m16.6m

Prepaid Expenses

2.6m2.9m3.3m

Inventories

21.0m27.4m39.5m

Current Assets

80.3m94.0m92.1m

PP&E

12.4m14.1m14.9m

Goodwill

23.8m29.9m40.0m

Total Assets

126.3m153.1m188.3m

Accounts Payable

1.5m1.7m2.6m

Short-term debt

1.8m

Current Liabilities

13.2m19.8m20.9m

Long-term debt

14.0m

Total Debt

15.7m

Total Liabilities

16.6m22.9m40.2m

Common Stock

207.0k211.0k217.0k

Additional Paid-in Capital

93.1m98.4m105.9m

Retained Earnings

28.3m45.8m57.0m

Total Equity

109.8m130.2m148.1m

Debt to Equity Ratio

0.1 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.2 x1.2 x1.3 x

LeMaitre Vascular Cash Flow

Annual

USDFY, 2017FY, 2018FY, 2019

Net Income

17.2m22.9m17.9m

Depreciation and Amortization

4.1m4.3m5.4m

Accounts Receivable

(1.5m)(1.3m)(1.3m)

Inventories

(1.4m)(4.3m)(11.3m)

Accounts Payable

1.5m4.3m(596.0k)

Cash From Operating Activities

22.9m19.5m14.2m

Purchases of PP&E

(6.4m)(3.1m)(3.8m)

Cash From Investing Activities

(29.0m)(7.1m)(24.1m)

Dividends Paid

(4.2m)(5.4m)(6.7m)

Cash From Financing Activities

80.0k(4.4m)(4.6m)

Net Change in Cash

(5.2m)7.2m(14.5m)

LeMaitre Vascular Ratios

USDQ1, 2017

Financial Leverage

1.2 x

LeMaitre Vascular Operating Metrics

FY, 2017FY, 2018FY, 2019

Facilities

13 22

Facilities Leased (US), square feet

82.91 k82.91 k109.35 k

Facilities Leased Internationally, square feet

21.57 k8.73 k13.95 k

Facilities Owned Internationally, square feet

6.14 k12.96 k

Product Lines

15 16 15

Sales Representatives

90 108 112

LeMaitre Vascular Employee Rating

2.419 votes
Culture & Values
2.5
Work/Life Balance
3.2
Senior Management
2.2
Salary & Benefits
2.6
Career Opportunities
2.2
Source